Anti-tumor activity of WK88-1, a novel geldanamycin derivative, in gefitinib-resistant non-small cell lung cancers with Met amplification

Although epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been introduced for the treatment of non-small cell lung cancer (NSCLC), the emergence of secondary T790M mutation in EGFR or amplification of the Met proto-oncogene restrain the clinical success of EGFR-TKIs. Sinc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Jang, Won-Jun, Jung, Sung-Keun, Kang, Jong-Soon, Jeong, Joo-Won, Bae, Moon-Kyoung, Joo, Sang Hoon, Park, Gyu Hwan, Kundu, Joydeb K, Hong, Young-Soo, Jeong, Chul-Ho
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462346/
https://ncbi.nlm.nih.gov/pubmed/25117641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12497
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados